Biotech firm DYD develops saliva-based diabetes test kit

By Kim Dong-young Posted : February 17, 2025, 16:15 Updated : February 17, 2025, 16:15
이미지 확대
DYDs glycated albumin measuring device for diabetes diagnosis Courtesy of DYD
DYD's diabetes diagnosis kit/ Courtesy of DYD
 
SEOUL, February 17 (AJP) - South Korean biotechnology company DYD announced plans on Monday to introduce a diabetes diagnostic kit capable of detecting the disease through saliva samples in under one minute.

The device aims to provide a less invasive alternative to traditional blood-based testing.

The diagnostic kit measures glycated albumin, a key biomarker for diabetes, using semiconductor biosensor technology that integrates next-generation surface technology with antibody conjugation techniques.

DYD’s platform has already received technology certification from the Ministry of Trade, Industry and Energy in South Korea. Additionally, the company has completed reproducibility verification through clinical trials conducted at Maryland Medical Center in the United States.

The saliva-based testing method offers significant advantages over conventional blood-based diagnostics.

“We aim to provide a more convenient and accurate monitoring environment for diabetes patients worldwide through our entry into the global diagnostic kit market,” a DYD spokesperson said.
Kim Dong-young Business Reporter
Kim Dong-young

Copyright ⓒ Aju Press All rights reserved.

0 comments
0 / 300

Are you sure you want to delete this comment?

Close

You can write comments after logging in.
Do you want to log in?

Close

You have already participated.

Close

Related

기사 이미지 확대 보기
닫기